Floxuridine Injection, Powder, Lyophilized, For Solution
Product Images NDC 81643-9270

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Floxuridine (NDC 81643-9270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jnd Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Floxuridine For Injection Usp 1)

FDA Label Image

Floxuridine Cerona (Floxuridine For Injection Usp 2)

Floxuridine Cerona (Floxuridine For Injection Usp 2)
This is a prescription-only medication for intra-arterial use. The usual dosage should be determined by the package insert. It is a powder for reconstitution of floxuridine. The reconstituted solution should be stored at 2° to 8°C for not longer than 2 weeks. The medication is distributed by Cerona Therapeutics and is contained in a 5 mL vial. The medication should be stored between 20° to 25°C before being reconstituted for use.*
FDA Label Image

Representative Carton Serialization Image (Floxuridine For Injection Usp 3)

Representative Carton Serialization Image (Floxuridine For Injection Usp 3)
This is a product identification and tracking code that includes a GTIN (Global Trade Item Number) and an SN (Serial Number). It also includes a T Lot number and an expiration date. It is not possible to determine the type or purpose of the product from this information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.